Molina Shares Tumble 9% as Obamacare, Medicaid Worries Overshadow Q2 Beat
MOH sits 66% above its 52-week low of $121.06.
Summary
Molina Healthcare shares dropped 9% premarket Thursday despite Q2 beats on profit and revenue, as investors fixated on mounting pressures in its Marketplace and Medicaid segments. The company raised full-year adjusted EPS guidance by just $0.25 to at least $5.25, disappointing analysts who expected a larger hike. Higher medical costs from sicker Obamacare enrollees and the expiration of enhanced subsidies are driving attrition, while Medicaid faces headwinds from state budget constraints and new eligibility checks. Baird flagged incremental membership losses as a growing risk into 2027. The earnings call at 8 a.m. ET will be critical for management to address the 2027 earnings outlook.
At the time of this announcement, MOH was trading at $201.26 on NYSE in the Life Sciences sector, with a market capitalization of approximately $11.9B. The 52-week trading range was $121.06 to $244.89. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.